Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Abrdn Healthcare InvestorsNYSE: HQH
Change in Working Capital · Q4 FY2024 · quarter ended Dec 2024
Change in working capital outflow grows to $43.01M
Q4 FY2024 change in working capital was $43.01M, compared with $0 a year earlier.
Context
- Change in working capital amounted to 0.0% of revenue in FY2024, unchanged from a year earlier.
- Change in working capital increased in 0 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2024
- 0 USD
- Year-over-year change
- —
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
| FY2020 | 2020-12-31 | 0 | — |
Change in Working Capital vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's FY2024 change in working capital of $0 is the smallest of the 10 companies compared; the peer median is $7.06M.
- Change in working capital amounts to 0.0% of revenue for HQH, versus a peer median of 3.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $27.76M | +1764.2% | -62.3% | 15.6% | |
| LTM Mar 2026 | $13.63M | +145.4% | -8.2% | 4.9% | |
| LTM Mar 2026 | $11.65M | +1485.4% | — | 4.8% | |
| LTM Mar 2026 | $10.63M | -76.3% | — | 1.3% | |
| LTM Mar 2026 | $7.61M | -175.1% | — | 3.9% | |
| LTM Mar 2026 | $7.3M | -90.5% | — | 3.2% | |
KBDCKayne Anderson BDC, Inc. | LTM Mar 2026 | $7.06M | -97.7% | — | 3.6% |
| LTM Mar 2026 | $4.28M | +234.4% | — | 5.7% | |
| LTM Mar 2026 | $2.38M | -89.7% | +100.0% | 1.1% | |
| FY2024 | $0 | — | — | 0.0% | |
| Peer median (excluding HQH) | $7.06M | -76.3% | -8.2% | 3.9% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Net Income | 241.2M | 155.18M | (194.23M) | 56.33M | 184.95M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (241.2M) | (155.18M) | 194.23M | (56.33M) | (184.95M) |
| Operating Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 |
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.